Daisy Zamora, PhD

  • 2Articles
  • 9.9KReads1
  • 2017–2022Active
  • 21Collaborators
  • 50Citations2

About

Daisy Zamora, PhD, is affiliated with the Department of Psychiatry at the University of North Carolina, Chapel Hill. Zamora has published research focused on treatment approaches for schizophrenia and schizoaffective disorders, including clinical trials investigating add-on pramipexole and raloxifene combined with antipsychotics. Contributions span from 2017 to 2022 in Psychiatrist.com journals. Frequent collaborators include John M. Davis, Linda Levi, Mark Weiser, Adam Noy, and Adela M. Ciobanu.

Publications

JCP
Add-on Pramipexole for Schizophrenia
Original Research

Add-on Pramipexole for Schizophrenia

August 1, 2022

Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test...
, , , et al
JCP
Original Research

Raloxifene in Postmenopausal Women With Schizophrenia

August 23, 2017

The estrogen protection hypothesis of schizophrenia was introduced in the late 1980s to explain  gender-related differences in epidemiology and clinical features. This study examines whether raloxifene, an estrogen agonist,...
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe